By comparing the present and previous studies17, CCL20 was commonly downregulated in HCC with β-catenin signaling activation, although there was no difference of CCL5 expression between human and mouse HCC cells with and without exon 3 skipping of β-catenin in this study. The gene discussed is CCL5; the disease is hepatocellular carcinoma.